• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

    2/9/24 10:26:34 AM ET
    $BIOS
    Blank Checks
    Finance
    Get the next $BIOS alert in real time by email
    SC 13G/A 1 BioPlusAcquisitionCorp..txt BIOPLUS ACQUISITION CORP 13GA Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No._1)* (Name of Issuer) BioPlus Acquisition Corp. (Title of Class of Securities) Class A Ordinary Share, par value $0.0001 per share (CUSIP Number) G11217117 (Date of Event Which Requires Filing of this Statement) 12/31/2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. G11217117 (1) Names of reporting persons Polar Asset Management Partners Inc. (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Citizenship or place of organization Ontario, Canada Number of shares beneficially owned by each reporting person with: (5) Sole voting power 0 (6) Shared voting power (7) Sole dispositive power 0 (8) Shared dispositive power (9) Aggregate amount beneficially owned by each reporting person 0 (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 0.0% (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: BioPlus Acquisition Corp. Item 1(b) Address of issuer's principal executive offices: 260 MADISON AVENUE, SUITE 800, NEW YORK, NY, 10016 2(a) Name of person filing: This statement is filed by Polar Asset Management Partners Inc., a company incorporated under the laws of Ontario, Canada, which serves as the investment advisor to Polar Multi-Strategy Master Fund, a Cayman Islands exempted company ("PMSMF") and certain managed account (together with PMSMF, the Polar Vehicles) with respect to the shares directly held by the Polar Vehicles. 2(b) Address or principal business office or, if none, residence: 16 York Street, Suite 2900, Toronto, ON, Canada M5J 0E6. 2(c) Citizenship: Canada 2(d) Title of class of securities: Class A Ordinary Share, par value $0.0001 per share 2(e) CUSIP Number: G11217117 Item 3. [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); [x] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: The Reporting Person is an investment fund manager, portfolio manager, exempt market dealer and commodity trading manager registered with the Ontario Securities Commission. Item 4. Ownership as of December 31, 2023 1. Polar Asset Management Partners Inc. (a) Amount beneficially owned: 0 (b) Percent of class: 0.0% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 Item 5.Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]. Instruction. Dissolution of a group requires a response to this item. Not applicable Item 6. Ownership of More than 5 Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reporting on by the Parent Holding Company or Control Person. Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications By signing below I certify that, to the best of his/her knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 9, 2024 POLAR ASSET MANAGEMENT PARTNERS INC. By: /s/ Andrew Ma Name: Andrew Ma Title: Chief Compliance Officer
    Get the next $BIOS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BIOS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BIOS
    Financials

    Live finance-specific insights

    See more
    • Purple Innovation Announces Cooperative Framework with Coliseum Capital

      Company to Welcome New Directors to Board Adam Gray to Serve as Board Chair Gary DiCamillo to Continue to Serve as Lead Independent Director Company Will Redeem Cumulative Voting Proportional Representation Preferred Linked Stock Purple Innovation, Inc. (NASDAQ:PRPL) ("Purple" or the "Company"), a comfort innovation company known for creating the "World's First No Pressure® Mattress," today announced that it has entered into a binding Memorandum of Understanding to establish a cooperative governance framework (the "Planned Cooperation Agreement") with Coliseum Capital Management, LLC (together with its managed funds and accounts, "Coliseum"), the largest stockholder of the Company o

      4/13/23 4:05:00 PM ET
      $ADES
      $BIOS
      $LAZY
      $LOGI
      Major Chemicals
      Industrials
      Blank Checks
      Finance

    $BIOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

      SC 13G/A - BioPlus Acquisition Corp. (0001856653) (Subject)

      2/12/24 4:14:06 PM ET
      $BIOS
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

      SC 13G/A - BioPlus Acquisition Corp. (0001856653) (Subject)

      2/9/24 10:26:34 AM ET
      $BIOS
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)

      SC 13G/A - BioPlus Acquisition Corp. (0001856653) (Subject)

      2/7/24 2:00:23 PM ET
      $BIOS
      Blank Checks
      Finance

    $BIOS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

      New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. ("BIOS" or the "Company") (NASDAQ:BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have mutually agreed to terminate their previously announced business combination agreement and plan of reorganization (the "Business Combination Agreement"), effective as of October 4, 2023 and (ii) it intends to liquidate as soon as practicable after October 4, 2023 and to return funds to holders of its Class A ordinary shares that were included in the units issued in the Company's initial public offering ("Public Shares"). The Business Combination Agreement was dated as of May 2, 2023. The pa

      10/4/23 7:30:00 AM ET
      $BIOS
      Blank Checks
      Finance
    • Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

      EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. ("Avertix" or the "Company"), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation (dba BioPlus Acquisition Corp.) ("BIOS") (NASDAQ:BIOS), a special purpose acquisition company, announced today that the two companies have mutually agreed to terminate their proposed business combination. "While we were enthusiastic about the potential business combination with BIOS, we mutually agreed that the current market conditions are not co

      10/4/23 7:30:00 AM ET
      $BIOS
      Blank Checks
      Finance
    • Carbonhand is available for Veterans in the US

      Bioservo signs a Sales Agent agreement with Trivet Medical LLC for sales of Carbonhand to Hospitals, Clinics, and Medical Centers within the Veterans Health Administration and Department of Defense in the US. With the first Sales Agent in place, the grip-strengthening device Carbonhand is available for all US Veterans suffering from impaired hand function. KISTA, Sweden, Aug. 29, 2023 /PRNewswire/ -- Trivet Medical LLC is a specialized strategic sales and distribution LLC, highly focused on commercializing disruptive, best-in-class med-tech devices and technologies. Founded by Charles Coyle, Trivet Medical's mission is to develop underrepresented and underserved healthcare conditions through

      8/29/23 3:03:00 AM ET
      $BIOS
      Blank Checks
      Finance

    $BIOS
    SEC Filings

    See more
    • SEC Form 15-12G filed by BioPlus Acquisition Corp.

      15-12G - BioPlus Acquisition Corp. (0001856653) (Filer)

      10/16/23 4:15:07 PM ET
      $BIOS
      Blank Checks
      Finance
    • SEC Form 25-NSE filed by BioPlus Acquisition Corp.

      25-NSE - BioPlus Acquisition Corp. (0001856653) (Subject)

      10/6/23 4:03:10 PM ET
      $BIOS
      Blank Checks
      Finance
    • SEC Form RW filed by BioPlus Acquisition Corp.

      RW - BioPlus Acquisition Corp. (0001856653) (Filer)

      10/4/23 7:39:57 AM ET
      $BIOS
      Blank Checks
      Finance

    $BIOS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Bioplus Sponsor Llc

      4 - BioPlus Acquisition Corp. (0001856653) (Issuer)

      6/12/23 9:17:36 PM ET
      $BIOS
      Blank Checks
      Finance